Studies have indicated that rhEPO effectively maintains Hb levels during chemotherapy, reduces transfusion needs, and improves perioperative anemia (Cao et al., 2020; Guan et al., 2020; Kaufner et al., 2020). Here, GSTM1 is linked to anemia.